Jill L. Silverman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jill L. Silverman has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- James I. Koenig
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA
2 shared publications Dana L. Brady
1 shared publication
Latest Publications
- 1 August 2007
- Published by Elsevier in Hormones and Behavior
- Vol. 52 (2) , 146-155
Evidence for the involvement of ERβ and RGS9-2 in 17-β estradiol enhancement of amphetamine-induced place preference behavior
- 1 August 2007
- Published by Elsevier in Hormones and Behavior
- Vol. 52 (2) , 146-155
Evidence for the involvement of ERβ and RGS9-2 in 17-β estradiol enhancement of amphetamine-induced place preference behavior
- 1 October 2004
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 15 (15) , 2433-2436
Estrogen modulates RGS9 expression in the nucleus accumbens
Estrogen enhances psychostimulant-induced dopamine receptor-mediated behaviors. One possible mechanism for this enhancement is modulation of the expression of the regulators of G-protein signaling (RGS) proteins. Ovariectomized (OVX) rats received empty s.c. implants or implants packed with 17β estradiol. Two weeks later the rats were given a single injection of various dopaminergic agents or saline. Estrogen administration to OVX rats selectively reduced RGS9 mRNA expression in the nucleus accumbens shell, but not core. Treating rats with D1 and D2 dopamine receptor agonists or amphetamine failed to change RGS9 mRNA expression in either OVX or OVX rats receiving estrogen. Our findings provide evidence for estrogen as a factor that enhances dopamine receptor signaling by altering RGS9 mRNA expression which could underlie gender specific patterns of psychostimulant abuse.
- 1 October 2004
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 15 (15) , 2433-2436
Estrogen modulates RGS9 expression in the nucleus accumbens
Estrogen enhances psychostimulant-induced dopamine receptor-mediated behaviors. One possible mechanism for this enhancement is modulation of the expression of the regulators of G-protein signaling (RGS) proteins. Ovariectomized (OVX) rats received empty s.c. implants or implants packed with 17β estradiol. Two weeks later the rats were given a single injection of various dopaminergic agents or saline. Estrogen administration to OVX rats selectively reduced RGS9 mRNA expression in the nucleus accumbens shell, but not core. Treating rats with D1 and D2 dopamine receptor agonists or amphetamine failed to change RGS9 mRNA expression in either OVX or OVX rats receiving estrogen. Our findings provide evidence for estrogen as a factor that enhances dopamine receptor signaling by altering RGS9 mRNA expression which could underlie gender specific patterns of psychostimulant abuse.